Abstract
Germline mutations in the tumor suppressor gene BRCA1 predispose women to breast cancer, however somatic mutations in the gene are rarely detected in sporadic cancers. To understand this phenomenon, we examined mouse models carrying conditional disruption of Brca1 in mammary epithelium in either p53 wild type (wt) or heterozygous backgrounds. Although a p53+/− mutation significantly accelerated tumorigenesis, both strains developed mammary tumors in a stochastic fashion, suggesting that multiple factors, in addition to p53 mutations, may be involved in Brca1 related tumorigenesis. A unique feature of Brca1 mammary tumors is their highly diverse histopathology accompanied by severe chromosome abnormalities. The tumors also display extensive genetic/molecular alterations, including overexpression of ErbB2, c-Myc, p27 and Cyclin D1 in the majority of tumors, while they were virtually ERα and p16 negative. Translocations involving p53 were also identified which lead to abnormal RNA and protein products. In addition, we generated cell lines from mammary tumors and found that the cells retained many of the genetic changes found in the primary tumors, suggesting that these genes may be players in Brca1-associated tumorigenesis. Despite their distinct morphology, all cultured tumor cells were Tamoxifen resistant but highly sensitive to Doxorubicin or γ-irradiation, suggesting that these methods would be effective in treatment of this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberg AJ, Helzlsouer KJ . 1997 Curr. Opin. Oncol. 9: 505–511
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET . 1999 Proc. Natl. Acad. Sci. USA 96: 11866–11871
Barbareschi M, van Tinteren H, Mauri FA, Veronese S, Peterse H, Maisonneuve P, Caffo O, Scaioli M, Doglioni C, Galligioni E, Dalla Palma P, Michalides R . 2000 Int. J. Cancer 89: 236–241
Barnes DM, Gillett CE . 1998 Breast Cancer Res. Treat. 52: 1–15
Bieche I, Khodja A, Lidereau R . 1999 Genes Chromosomes Cancer 24: 255–263
Bieche I, Lidereau R . 1995 Genes Chromosomes Cancer 14: 227–251
Bonsing BA, Corver WE, Fleuren GJ, Cleton-Jansen AM, Devilee P, Cornelisse CJ . 2000 Genes Chromosomes Cancer 28: 173–183
Brison O . 1993 Biochim. Biophys. Acta 1155: 25–41
Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX . 2001 Oncogene 20: 1445–1454
Brody LC, Biesecker BB . 1998 Medicine (Baltimore) 77: 208–226
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE . 2000 Oncogene 19: 968–988
Cardiff RD, Sinn E, Muller W, Leder P . 1991 Am. J. Pathol. 139: 495–501
Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R . 1998 Mol. Cell 2: 317–328
Cortez D, Wang Y, Qin J, Elledge SJ . 1999 Science 286: 1162–1166
Darzynkiewicz Z . 1995 J. Cell. Biochem. 58: 151–159
Deng CX, Brodie SG . 2000 Bioessays 22: 728–737
Deng CX, Scott F . 2000 Oncogene 19: 1059–1064
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A . 1992 Nature 356: 215–221
Easton D . 1997 Nat. Genet. 16: 210–211
Fisher DE . 1994 Cell 78: 539–542
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y . 1994 Science 266: 120–122
Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK . 2001 J. Biol. Chem. 13: 13
Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH . 1996 Nat. Genet. 12: 191–194
Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA . 1998 Science 281: 1009–1012
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . 1992 Proc. Natl. Acad. Sci. USA 89: 10578–10582
Hakem R, de la Pompa JL, Sirad C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossand J, Mak TW . 1996 Cell 85: 1009–1023
Harvey M, McArthur MJ, Montgomery Jr CA, Bradley A, Donehower LA . 1993 FASEB J. 7: 938–943
Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA, Windle JJ . 1997 Mol. Cell. Biol. 17: 723–731
Hutchinson JN, Muller WJ . 2000 Oncogene 19: 6130–6137
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ . 1998 Oncogene 16: 1097–1112
Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V, Olsson H . 1997 Eur. J. Cancer 33: 362–371
Kinzler KW, Vogelstein B . 1997 Nature 386: 761, 763
Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P . 1986 Cell 45: 485–495
Liu CY, Flesken-Nikitin A, Li S, Zeng Y, Lee WH . 1996 Genes Dev. 10: 1835–1843
Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A . 1997 Genes Dev. 11: 1226–1241
Menard S, Tagliabue E, Campiglio M, Pupa SM . 2000 J. Cell. Physiol. 182: 150–162
Milde-Langosch K, Bamberger AM, Methner C, Rieck G, Loning T . 2000 Int. J. Cancer 87: 468–472
Moynahan ME, Chiu JW, Koller BH, Jasin M . 1999 Mol. Cell 4: 511–518
Mueller A, Odze R, Jenkins TD, Shahsesfaei A, Nakagawa H, Inomoto T, Rustgi AK . 1997 Cancer Res. 57: 5542–5549
O'Brien KA, Lemke SJ, Cocke KS, Rao RN, Beckmann RP . 1999 Biochem. Biophys. Res. Commun. 260: 658–664
Orsetti B, Courjal F, Cuny M, Rodriguez C, Theillet C . 1999 Oncogene 18: 6262–6270
Osborne RJ, Hamshere MG . 2000 Cancer Res. 60: 3706–3712
Paterson JW . 1998 Dis. Markers 13: 261–274
Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K . 1998 Cancer Res. 58: 1839–1842
Rodriguez C, Causse A, Ursule E, Theillet C . 2000 Genes Chromosomes Cancer 27: 76–84
Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM . 1999 Mol. Cell. Biol. 19: 4843–4854
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997a Cell 88: 265–275
Scully RCJ, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM . 1997b Cell 90: 425–436
Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Guan XY, Ried T, Deng CX . 1998 Oncogene 17: 3115–3124
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . 1987 Science 235: 177–182
Staff S, Nupponen NN, Borg A, Isola JJ, Tanner MM . 2000 Genes Chromosomes Cancer 28: 432–442
Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF . 1984 Science 226: 466–468
Walker RA . 1999 J. Pathol. 188: 229–230
Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN . 1997 Oncogene 15: 143–157
Wang Q, Zhang H, Fishel R, Greene MI . 2000 Oncogene 19: 6152–6158
Wang Q, Zhang H, Kajino K, Greene MI . 1998 Oncogene 17: 1939–1948
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R . 1996 Nat. Genet. 14: 430–440
Xu CF, Solomon E . 1996 Semin. Cancer Biol. 7: 33–40
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX . 1999a Nat. Genet. 22: 37–43
Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX . 1999b Mol. Cell 3: 389–395
Xu X, Qiao W, Linke SP, Cao L, Li W, Furth PA, Harris CC, Deng CX . 2001 Nat. Genet. 28: 266–271
Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392
Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH . 1999 Science 285: 747–750
Acknowledgements
We would like to thank D Shanmugarajah for technical assistance and Gertraud Robinson for critical reading of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brodie, S., Xu, X., Qiao, W. et al. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20, 7514–7523 (2001). https://doi.org/10.1038/sj.onc.1204929
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204929
Keywords
This article is cited by
-
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage
Oncogenesis (2022)
-
Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice
Scientific Reports (2021)
-
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
Nature Communications (2020)
-
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors
Experimental & Molecular Medicine (2018)
-
MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland
Oncogenesis (2016)